ezetimibe has been researched along with cyclosporine in 15 studies
| Studies (ezetimibe) | Trials (ezetimibe) | Recent Studies (post-2010) (ezetimibe) | Studies (cyclosporine) | Trials (cyclosporine) | Recent Studies (post-2010) (cyclosporine) |
|---|---|---|---|---|---|
| 2,484 | 563 | 1,465 | 377 | 2 | 170 |
| 2,484 | 563 | 1,465 | 30,547 | 3,802 | 6,558 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 9 (60.00) | 29.6817 |
| 2010's | 6 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, TK; Ensom, MH; Kiang, TK | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Artursson, P; Haglund, U; Karlgren, M; Kimoto, E; Lai, Y; Norinder, U; Vildhede, A; Wisniewski, JR | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Burton, I; Koshman, SL; Lalonde, LD; Pearson, GJ; Tymchak, WJ | 1 |
| Ito, MK | 1 |
| Heemann, U; Kohnle, M; Kribben, A; Philipp, T; Pietruck, F; Witzke, O | 1 |
| Bergman, AJ; Burke, J; Frick, G; Gottesdiener, K; Greenberg, HE; Johnson-Levonas, AO; Kosoglou, T; Kraft, WK; Larson, P; Murphy, G; Paolini, JF; Reyderman, L; Statkevich, P | 1 |
| Bergman, AJ; Burke, J; Gottesdiener, K; Johnson-Levonas, AO; Kosoglou, T; Larson, P; Maxwell, SE; Murphy, G; Paolini, JF; Reyderman, L; Robson, R; Statkevich, P | 1 |
| Barsotti, G; Carpi, A; Consani, C; Manca-Rizza, G; Mantuano, E; Marchetti, V; Panichi, V; Paoletti, S; Sbragia, G; Taccola, D | 1 |
| Narushima, K; Suzuki, H; Takada, T; Yamanashi, Y | 1 |
| Baynes, AC; Chaggar, P; Fildes, JE; O'Neill, N; Ritchie, J; Shah, MK; Shaw, SM; Williams, SG; Yonan, N | 1 |
| Majidi, R; Moghaddasi, S; Nouri-Majalan, N | 1 |
| Lempp, FA; Urban, S | 1 |
3 review(s) available for ezetimibe and cyclosporine
| Article | Year |
|---|---|
UDP-glucuronosyltransferases and clinical drug-drug interactions.
Topics: Clinical Trials as Topic; Drug Interactions; Enzyme Activation; Enzyme Induction; Glucuronides; Glucuronosyltransferase; Humans; Pharmaceutical Preparations; Pharmacogenetics; Polymorphism, Genetic | 2005 |
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Inhibitors of hepatitis B virus attachment and entry.
Topics: Animals; Antibodies, Monoclonal; Antiviral Agents; Azetidines; Cyclosporine; Ezetimibe; Hepatitis B Antibodies; Hepatitis B virus; Hepatocytes; Humans; Immunoglobulins; Lipopeptides; Mice; Organic Anion Transporters, Sodium-Dependent; Symporters; Virus Attachment; Virus Internalization | 2014 |
4 trial(s) available for ezetimibe and cyclosporine
| Article | Year |
|---|---|
Ezetimibe for the treatment of uncontrolled hypercholesterolemia in patients with high-dose statin therapy after renal transplantation.
Topics: Adult; Aged; Anticholesteremic Agents; Azetidines; Cholesterol; Cyclosporine; Drug Therapy, Combination; Ezetimibe; Fatty Acids, Monounsaturated; Female; Fluvastatin; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Indoles; Kidney Transplantation; Liver; Male; Middle Aged; Muscle, Skeletal; Pravastatin; Simvastatin; Tacrolimus | 2006 |
Effects of ezetimibe on cyclosporine pharmacokinetics in healthy subjects.
Topics: Adult; Anticholesteremic Agents; Area Under Curve; Azetidines; Cross-Over Studies; Cyclosporine; Dose-Response Relationship, Drug; Drug Interactions; Drug Monitoring; Ezetimibe; Female; Humans; Immunosuppressive Agents; Male | 2006 |
Interaction of single-dose ezetimibe and steady-state cyclosporine in renal transplant patients.
Topics: Adult; Aged; Anticholesteremic Agents; Area Under Curve; Azetidines; Cyclosporine; Dose-Response Relationship, Drug; Drug Interactions; Drug Monitoring; Ezetimibe; Female; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged | 2006 |
The efficacy and tolerability of ezetimibe in cardiac transplant recipients taking cyclosporin.
Topics: Adult; Aged; Anticholesteremic Agents; Azetidines; Cholesterol; Cyclosporine; Double-Blind Method; Ezetimibe; Female; Heart Transplantation; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Immunosuppressive Agents; Lipoproteins, LDL; Male; Middle Aged; Placebos; Safety | 2009 |
8 other study(ies) available for ezetimibe and cyclosporine
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.
Topics: Atorvastatin; Biological Transport; Drug Interactions; Estradiol; Estrone; HEK293 Cells; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Least-Squares Analysis; Liver; Liver-Specific Organic Anion Transporter 1; Models, Molecular; Multivariate Analysis; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Protein Isoforms; Pyrroles; Solute Carrier Organic Anion Transporter Family Member 1B3; Structure-Activity Relationship; Transfection | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Supratherapeutic response to ezetimibe administered with cyclosporine.
Topics: Anticholesteremic Agents; Atorvastatin; Azetidines; Cyclosporine; Drug Interactions; Ezetimibe; Heart Transplantation; Heptanoic Acids; Humans; Hyperlipidemias; Immunosuppressive Agents; Male; Middle Aged; Postoperative Complications; Pyrroles | 2005 |
Comment: supratherapeutic response to ezetimibe administered with cyclosporine.
Topics: Anticholesteremic Agents; Azetidines; Cholesterol, LDL; Cyclosporine; Drug Interactions; Ezetimibe; Humans; Immunosuppressive Agents | 2005 |
Safety and effects on the lipid and C-reactive protein plasma concentration of the association of ezetimibe plus atorvastatin in renal transplant patients treated by cyclosporine-A: a pilot study.
Topics: Aged; Anticholesteremic Agents; Atorvastatin; Azetidines; C-Reactive Protein; Cyclosporine; Drug Combinations; Ezetimibe; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Immunosuppressive Agents; Kidney Function Tests; Kidney Transplantation; Lipids; Male; Middle Aged; Pilot Projects; Pyrroles; Triglycerides | 2006 |
Niemann-pick C1-like 1 mediates alpha-tocopherol transport.
Topics: alpha-Tocopherol; Animals; Anticholesteremic Agents; Azetidines; Biological Transport; Caco-2 Cells; Cholesterol; Cyclosporine; Ezetimibe; Humans; Immunohistochemistry; Intestinal Absorption; Male; Membrane Proteins; Membrane Transport Proteins; Micelles; Phosphatidylcholines; Rats; Rats, Wistar; Taurocholic Acid; Temperature; Time Factors; Vitamin A | 2008 |
Impaired kidney allograft function following ezetimibe therapy.
Topics: Anticholesteremic Agents; Azetidines; Creatinine; Cyclosporine; Ezetimibe; Humans; Kidney Transplantation; Male; Middle Aged; Primary Graft Dysfunction | 2011 |